Abdominal Rectus Diastasis (ARD) Reconstruction (ARD)

October 2, 2023 updated by: Anders Thorell, Karolinska Institutet

Minimally Invasive Abdominal Wall Reconstruction in Symptomatic Rectus Diastasis

The aim of this study is to investigate whether abdominal wall reconstruction through laparoscopic surgery can be recommended as a safe treatment alternative for patients with symptomatic rectus diastasis, and if this type of treatment leads to improved quality of life, trunk stability and reduced pain.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Investigate whether surgical reconstruction with laparoscopic technique can lead to improved quality of Life, trunk stability and reduced pain in patients with symptomatic rectus diastasis. The study will also compare two different laparoscopic surgery methods for abdominal wall reconstruction: narrowing of linea alba with continuous suture with or without mesh.

Study Type

Interventional

Enrollment (Estimated)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Region Stockholm
      • Stockholm, Region Stockholm, Sweden, SE-116 91
        • Recruiting
        • Karolinska Institutet, Ersta Hospital
        • Contact:
        • Principal Investigator:
          • Anders Thorell, Ass. Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Rectus diastasis ≥3 cm
  • BMI =<28 kg/m2
  • non smoker
  • abdominal instability,
  • abdominal wall and/or lower back pain despite physical therapy / structured physical exercise for at least 6 months

Exclusion Criteria:

  • BMI >28 kg/m2
  • Smoking
  • Ongoing immunosuppressive therapy
  • Current pregnancy ≥16 weeks gestational age for the last 12 months
  • Pregnant or women who wish to become pregnant
  • Previously extensive abdominal wall surgery incl hernia surgery (NOT including sectio, appendectomy, small umbilical herniae)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Suture
laparoscopic narrowing of linea alba with continuous suture
surgical reconstruction with laparoscopic technique
Active Comparator: suture and mesh
narrowing of linea alba with continuous suture and mesh
surgical reconstruction with laparoscopic technique

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of recurrence
Time Frame: 1 year
computed tomography
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Analog Pain Scale (VAS)
Time Frame: 1 year, 3 years
Scale from 0 to 10, where 0 is no pain and 10 is the worst possible pain
1 year, 3 years
Abdominal stability
Time Frame: 1 year, 3 years
patient self-esteem by one question; do you feel that the instability of the abdominal wall has disappeared, yes/no/partially
1 year, 3 years
SF-36 Quality of Life instrument
Time Frame: 1 year, 3 years
The RAND-36 It is comprised of 36 items that assess eight health concepts: physical functioning, role limitations caused by physical health problems, role limitations caused by emotional problems, social functioning, emotional well-being, energy/fatigue, pain, and general health perceptions. Physical and mental health summary scores are also derived from the eight RAND-36 scales. Higher scores mean a better outcome.
1 year, 3 years
VHPQ is a questionnaire for the assessment of pre- and postoperative pain
Time Frame: 1 year, 3 years
The questionnaire comprises 20 questions The first six questions concern the level and duration of pain. The next seven questionsrelate to the impact on daily activities. The final questions deal with patient satisfaction and how physically demanding the patients regard their occupation. Pain intensity in the VHPQ is assessed using a 7-step fixed-point rating scale with steps linked to pain behavior rather than numbers or verbal descriptors of pain. Higher scores mean a worse outcome.
1 year, 3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anders Thorell, Professor, Karolinska Institutet

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 17, 2019

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

November 7, 2019

First Submitted That Met QC Criteria

November 28, 2019

First Posted (Actual)

December 2, 2019

Study Record Updates

Last Update Posted (Actual)

October 4, 2023

Last Update Submitted That Met QC Criteria

October 2, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rectus Diastasis

Clinical Trials on ARD

3
Subscribe